Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-048622

Chief Financial Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Buck Paul Chief Financial Officer 2013-08-28 Grant or award +50,000 $0.25 $12,500 534,867 D
Loading xslF345X03/v354044_4.xml…